BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34333121)

  • 1. Spectrum of Acute Neuropathy Associated With Covid-19: A Clinical and Electrophysiological Study of 13 Patients From a Single Center.
    Yaranagula SD; Koduri VKC
    Int J Infect Dis; 2021 Sep; 110():314-319. PubMed ID: 34333121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of Sensory Conduction Abnormalities in Guillain Barre Syndrome.
    Nagappa M; Wahatule R; Bindu PS; Sinha S; Taly AB
    Neurol India; 2022; 70(6):2393-2400. PubMed ID: 36537422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Guillain-Barrè syndrome triggered by SARS-CoV-2? Case report and literature review.
    Agosti E; Giorgianni A; D'Amore F; Vinacci G; Balbi S; Locatelli D
    Neurol Sci; 2021 Feb; 42(2):607-612. PubMed ID: 32643136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sural-sparing is seen in axonal as well as demyelinating forms of Guillain-Barré syndrome.
    Umapathi T; Li Z; Verma K; Yuki N
    Clin Neurophysiol; 2015 Dec; 126(12):2376-80. PubMed ID: 25743269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 50-Year-Old Patient with Guillain-Barré Syndrome after COVID-19: A Case Report.
    Chmiela T; Rzepka M; Krzystanek E; Gorzkowska A
    Medicina (Kaunas); 2021 Jul; 57(8):. PubMed ID: 34440980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Very Early Neurophysiological Study in Guillain-Barre Syndrome.
    Jin J; Hu F; Qin X; Liu X; Li M; Dang Y; Dang J
    Eur Neurol; 2018; 80(1-2):100-105. PubMed ID: 30347390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiologic-pathologic correlation in Guillain-Barré syndrome in children.
    Lu JL; Sheikh KA; Wu HS; Zhang J; Jiang ZF; Cornblath DR; McKhann GM; Asbury AK; Griffin JW; Ho TW
    Neurology; 2000 Jan; 54(1):33-9. PubMed ID: 10636122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early electrophysiological findings in acute inflammatory demyelinating polyradiculoneuropathy variant of Guillain-Barre syndrome in the Pakistani population - a comparison with global data.
    Wali A; Kanwar D; Khan SA; Khan S
    J Peripher Nerv Syst; 2017 Dec; 22(4):451-454. PubMed ID: 29091318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2-associated Guillain-Barré syndrome is a para-infectious disease.
    Li X; Wang Y; Wang H; Wang Y
    QJM; 2021 Nov; 114(9):625-635. PubMed ID: 34043803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The sural sensory nerve is usually spared in Guillain-Barre syndrome.
    Wee AS; Abernathy SD
    J Miss State Med Assoc; 2003 Aug; 44(8):251-5. PubMed ID: 14531230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of sensory nerve conduction studies in the diagnosis of Guillain-Barré syndrome.
    Freiha J; Zoghaib R; Makhoul K; Maalouf N; Riachi N; Chalah MA; Ayache SS; Ahdab R
    Clin Neurophysiol; 2021 May; 132(5):1157-1162. PubMed ID: 33780722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Electrophysiological subtypes of Guillain-Barré syndrome in Mexican adults].
    Zúñiga-González EA; Rodríguez-de la Cruz A; Millán-Padilla J
    Rev Med Inst Mex Seguro Soc; 2007; 45(5):463-8. PubMed ID: 18294437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on Electrophysiological Findings of Guillain Barre Syndrome Patients Attending the Department of Neurology in BSMMU.
    Das S; Khan RK; Alam SM; Chowdhury NH; Das P
    Mymensingh Med J; 2018 Jul; 27(3):631-640. PubMed ID: 30141456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guillain-Barré syndrome associated with SARS-CoV-2 infection. A systematic review.
    De Sanctis P; Doneddu PE; Viganò L; Selmi C; Nobile-Orazio E
    Eur J Neurol; 2020 Nov; 27(11):2361-2370. PubMed ID: 32757404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A variant of Guillain-Barre syndrome after SARS-CoV-2 vaccination: AMSAN.
    Tutar NK; Eyigürbüz T; Yildirim Z; Kale N
    Ideggyogy Sz; 2021 Jul; 74(7-08):286-288. PubMed ID: 34370408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guillain-Barré syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature.
    Scheidl E; Canseco DD; Hadji-Naumov A; Bereznai B
    J Peripher Nerv Syst; 2020 Jun; 25(2):204-207. PubMed ID: 32388880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sural nerve involvement in Guillain-Barré syndrome: Clinical and prognostic implications. A prospective cohort.
    López-Hernández JC; Rivas-Cruz MA; Galnares-Olalde JA; López-Alderete JA; López-Pizano A; Alcalá RE; Villanueva AV; Vargas-Cañas ES
    J Clin Neurosci; 2023 Apr; 110():48-52. PubMed ID: 36791495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 associated cranial nerve neuropathy: A systematic review.
    Finsterer J; Scorza FA; Scorza C; Fiorini A
    Bosn J Basic Med Sci; 2022 Feb; 22(1):39-45. PubMed ID: 34392827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guillain-Barré syndrome associated with SARS-CoV-2 infection: A systematic review and individual participant data meta-analysis.
    Hasan I; Saif-Ur-Rahman KM; Hayat S; Papri N; Jahan I; Azam R; Ara G; Islam Z
    J Peripher Nerv Syst; 2020 Dec; 25(4):335-343. PubMed ID: 33112450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensory nerve conduction in demyelinating and axonal Guillain-Barré syndromes.
    Kuwabara S; Ogawara K; Misawa S; Mizobuchi K; Sung JY; Kitano Y; Mori M; Hattori T
    Eur Neurol; 2004; 51(4):196-8. PubMed ID: 15159599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.